相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PD-1 disrupted CAR-T cells in the treatment of solid tumors: Promises and challenges
Eileen McGowan et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Enhancing Chimeric Antigen Receptor T-Cell Efficacy in Solid Tumors
Giovanni Fuca et al.
CLINICAL CANCER RESEARCH (2020)
Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia
Talha Badar et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2020)
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1-2 trial
Birgit Geoerger et al.
LANCET ONCOLOGY (2020)
CD19 CAR T cell product and disease attributes predict leukemia remission durability
Olivia C. Finney et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Patients Selection for Immunotherapy in Solid Tumors: Overcome the Naive Vision of a Single Biomarker
Diego Signorelli et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Naive T-cell Deficits at Diagnosis and after Chemotherapy Impair Cell Therapy Potential in Pediatric Cancers
Rajat K. Das et al.
CANCER DISCOVERY (2019)
A guide to manufacturing CAR T cell therapies
Philipp Vormittag et al.
CURRENT OPINION IN BIOTECHNOLOGY (2018)
Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia
Joseph A. Fraietta et al.
NATURE MEDICINE (2018)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Life and Death of Activated T Cells: How Are They Different from Naive T Cells?
Yifan Zhan et al.
FRONTIERS IN IMMUNOLOGY (2017)
Monocyte lineage-derived IL-6 does not affect chimeric antigen receptor T-cell function
Nathan Singh et al.
CYTOTHERAPY (2017)
Structure-activity relationship analysis of mitochondrial toxicity caused by antiviral ribonucleoside analogs
Zhinan Jin et al.
ANTIVIRAL RESEARCH (2017)
Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults
Rebecca A. Gardner et al.
BLOOD (2017)
Mitochondrial Dynamics Controls T Cell Fate through Metabolic Programming
Michael D. Buck et al.
CELL (2016)
Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy
Madhusudhanan Sukumar et al.
CELL METABOLISM (2016)
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
Omkar U. Kawalekar et al.
IMMUNITY (2016)
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction
Nicole E. Scharping et al.
IMMUNITY (2016)
Mitochondrial purine and pyrimidine metabolism and beyond
Liya Wang
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2016)
Early memory phenotypes drive T cell proliferation in patients with pediatric malignancies
Nathan Singh et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Chimeric Antigen Receptor T cells for B Cell Neoplasms: Choose the Right CAR for You
Marco Ruella et al.
CURRENT HEMATOLOGIC MALIGNANCY REPORTS (2016)
Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies
Saar Gill et al.
IMMUNOLOGICAL REVIEWS (2015)
Chimeric Antigen Receptor Therapy for Cancer
David M. Barrett et al.
ANNUAL REVIEW OF MEDICINE, VOL 65 (2014)
Relation of clinical culture method to T-cell memory status and efficacy in xenograft models of adoptive immunotherapy
David M. Barrett et al.
CYTOTHERAPY (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Cyclophosphamide Alters the Gene Expression Profile in Patients Treated with High Doses Prior to Stem Cell Transplantation
Ibrahim El-Serafi et al.
PLOS ONE (2014)
Nature of Tumor Control by Permanently and Transiently Modified GD2 Chimeric Antigen Receptor T Cells in Xenograft Models of Neuroblastoma
N. Singh et al.
Cancer Immunology Research (2014)
A human memory T cell subset with stem cell-like properties
Luca Gattinoni et al.
NATURE MEDICINE (2011)
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
Andres J. M. Ferreri et al.
LANCET (2009)
Apigenin Inhibits the GLUT-1 Glucose Transporter and the Phosphoinositide 3-Kinase/Akt Pathway in Human Pancreatic Cancer Cells
Laleh G. Melstrom et al.
PANCREAS (2008)
In vitro effect of fludarabine, cyclophosphamide, and cytosine arabinoside on chromosome breakage in Fanconi anemia patients: Relevance to stem cell transplantation
Miharu Yabe et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2007)
Antigen-specific T-cell memory is preserved in children treated for acute lymphoblastic leukemia
WN Haining et al.
BLOOD (2005)
Ifosfamide and cyclophosphamide: Effects on immunosurveillance
G Binotto et al.
ONCOLOGY (2003)
分享论文
